Cue Health Inc.
HLTHQ
$0.00
$0.000.00%
OTC PK
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Revenue | -85.33% | -62.41% | -63.26% | -55.14% | -21.78% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -85.33% | -62.41% | -63.26% | -55.14% | -21.78% |
| Cost of Revenue | -47.01% | -25.54% | -19.24% | 18.39% | 57.00% |
| Gross Profit | -985.16% | -413.99% | -169.80% | -142.21% | -106.01% |
| SG&A Expenses | -51.56% | -41.46% | -28.70% | -2.86% | 71.11% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -51.29% | -33.21% | -21.87% | 12.36% | 60.58% |
| Operating Income | -29.54% | -75.90% | -2,193.25% | -265.14% | -207.05% |
| Income Before Tax | -80.89% | -79.34% | -962.14% | -379.24% | -271.01% |
| Income Tax Expenses | 149.17% | 96.13% | -139.52% | -130.91% | -129.76% |
| Earnings from Continuing Operations | -92.45% | -99.92% | -546.54% | -482.01% | -324.56% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -92.45% | -99.92% | -546.54% | -482.01% | -324.56% |
| EBIT | -29.54% | -75.90% | -2,193.25% | -265.14% | -207.05% |
| EBITDA | -36.44% | -94.97% | -549.04% | -217.22% | -172.79% |
| EPS Basic | -86.41% | -81.79% | -432.18% | -513.65% | -340.94% |
| Normalized Basic EPS | -24.60% | -67.85% | -180.23% | -133.49% | -120.67% |
| EPS Diluted | -85.99% | -80.56% | -410.59% | -537.49% | -356.35% |
| Normalized Diluted EPS | -24.51% | -66.57% | -206.27% | -143.80% | -127.31% |
| Average Basic Shares Outstanding | 3.23% | 2.95% | 27.40% | 73.88% | 175.34% |
| Average Diluted Shares Outstanding | 2.11% | 0.78% | 22.11% | 60.83% | 145.44% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |